Get started
Author

Darin D. Carabenciov

Observed names: D Carabenciov, Darin Carabenciov
Observed institutions: Mayo Clinic, Neurology, Inc
OpenAlex ID: A5098937930
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
2025 · Kenneth J. C. Lim, Melinda Tan, et al. · Blood Cancer Journal · 19
PDF
Prophylactic dexamethasone to reduce risk of cilta-cel associated immune effector cell delayed neurotoxicity
2025 · Kenneth JC Lim, Ricardo Parrondo, et al. · Blood · 4
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH ‐wildtype
2024 · Yi Zhu, Darin D. Carabenciov, et al. · Brain Pathology · 4
Investigating the Role of Dexamethasone Prophylaxis for the Risk Reduction of Immune Effector Cell Delayed Neurotoxicity in Cilta-Cel Treated Patients
2026 · Kenneth Jin Chang Lim, Ricardo Daniel Parrondo, et al. · Transplantation and Cellular Therapy · 2
OA-41 Mitigating Cilta-cel-Associated Delayed Neurotoxicity in Patients with High Lymphocyte Expansion: A Prospective Observational Comparative Study of Prophylactic Cyclophosphamide
2026 · Christoph Schaefers, Melinda Tan, et al. · Clinical Lymphoma Myeloma & Leukemia
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity
2026 · Kenneth JC Lim, Melinda Tan, et al. · Blood Cancer Journal
PDF
Radiation Necrosis and Myelopathy Beyond the Targeted Field: A Case Series (P5-6.004)
2026 · Edanur Sahin, Darin D. Carabenciov, et al. · Neurology
P01.001 Bevacizumab use in adult pilocytic astrocytoma, a single center experience
2018 · M Ruff, D Carabenciov, et al. · Neuro-Oncology
PDF
Works count: 8
Citation count: 29
H-index: 3
I10-index: 1
Year
Topic
Type